Urinary Tract Infections

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/57

encourage image

There's no tags or description

Looks like no tags are added yet.

58 Terms

1
New cards

Most common route of UTI infection

Ascending (urethra upward)

2
New cards

Descending UTI route

Uncommon; bloodstream seeds urinary tract

3
New cards

Host defenses against UTI

Low urine pH, high osmolality, high urea, prostatic secretions, low vaginal pH (Lactobacillus)

4
New cards

UTI risk factors

Female, prior UTI, sex, pregnancy, menopause/spermicides, young/old age, catheter/enlarged prostate, poor hygiene

5
New cards

Classic UTI symptoms

Urgency, frequency, dysuria, cloudy/bloody urine, pelvic pain

6
New cards

Pyelonephritis symptoms

UTI symptoms + fever/chills, N/V, flank pain, hematuria

7
New cards

Prostatitis symptoms

Fever/chills, malaise, pain, dysuria, urgency, nocturia, retention

8
New cards

Urinalysis findings of UTI

Bacteriuria, pyuria (WBC >10), nitrite +, leukocyte esterase +

9
New cards

When to collect UA + urine culture

BEFORE starting antibiotics

10
New cards

Urine culture timing

Culture 1–2 days; susceptibilities 2–3 days

11
New cards

Most common UTI pathogen

E. coli (80–90%)

12
New cards

Community-acquired UTI pathogens

E. coli, Klebsiella, S. saprophyticus, E. faecalis

13
New cards

Hospital-acquired/cUTI pathogens

E. coli, Pseudomonas, Proteus, Enterobacter, Enterococcus

14
New cards

Catheter/neurogenic bladder pathogens

More resistant: Pseudomonas, Enterococcus

15
New cards

Prostatitis pathogens

E. coli, Klebsiella, Proteus, Enterococcus

16
New cards

Uncomplicated UTI definition

Bladder only; no fever, flank pain, or catheter

17
New cards

NOT complicated on their own

Male, diabetes, immunocompromise, BPH

18
New cards

Complicated UTI definition

Beyond bladder: fever, flank pain, prostatitis, obstruction, catheter

19
New cards

Nitrofurantoin (Macrobid) dose – uUTI

100 mg BID x 5 days

20
New cards

Nitrofurantoin pearls

Bladder only; avoid if CrCl <60; NOT for cUTI/pyelo

21
New cards

Bactrim DS dose – uUTI

160/800 mg BID x 3 days

22
New cards

Bactrim pearls – uUTI

Only if local resistance <20%; SJS/TEN, hyperkalemia

23
New cards

Fosfomycin (Monurol) dose

3 g once

24
New cards

Fosfomycin pearl

Inferior to other regimens; NOT for cUTI

25
New cards

Oral β-lactams for uUTI

Amox-clav, cefdinir, cefaclor, cefpodoxime x 3–7 days

26
New cards

Oral β-lactam pearls – uUTI

Only if others can't be used; inferior; OK in pregnancy

27
New cards

Cipro dose – uUTI

500 mg BID x 3 days

28
New cards

Cipro pearls – uUTI

Renally adjust, QTc, more ADRs; save for cUTI

29
New cards

Phenazopyridine (Azo)

200 mg TID, max 3 days; urinary analgesic

30
New cards

Non-drug UTI prevention

Cranberry, probiotics, hydration (prevent, don't cure)

31
New cards

Topical estrogen

Postmenopausal women; prevention only

32
New cards

Recurrent UTI definition

2 in 6 months or 3 in 1 year

33
New cards

Relapse vs. reinfection

Relapse <2 weeks; reinfection >2 weeks

34
New cards

FQ dose – cUTI

Cipro 500–750 mg BID or levo 750 mg daily x 5–7 days

35
New cards

FQ pearl – cUTI

Preferred oral; avoid if FQ in past 12 months or FQ-resistant isolate

36
New cards

Bactrim DS dose – cUTI

160/800 mg BID x 7 days

37
New cards

Bactrim pearl – cUTI

Preferred if susceptible; high resistance, check prior cultures

38
New cards

Oral β-lactam pearl – cUTI

Alternative only; high doses; avoid cefdinir/cefaclor

39
New cards

Nitrofurantoin/fosfomycin in cUTI

NOT appropriate (don't reach kidney/blood)

40
New cards

Ceftriaxone susceptibility and cefpodoxime

Does NOT predict cefpodoxime susceptibility

41
New cards

cUTI empiric approach steps

1) Severity (SOFA ≥2) 2) Resistance risk 3) Patient factors 4) Antibiogram (sepsis only)

42
New cards

Antibiogram susceptibility cutoff

≥80% sepsis; ≥90% septic shock

43
New cards

Preferred cUTI IV (sepsis or not)

3rd/4th gen cephs, pip-tazo, FQs

44
New cards

Carbapenems in cUTI

Preferred if sepsis; alternative if not; consider if prior ESBL

45
New cards

Aminoglycosides in cUTI

Alternative; 1–2 doses if ESBL concern

46
New cards

Ceftriaxone vs. cefepime in cUTI

Ceftriaxone if no Pseudo concern; cefepime/ceftaz if Pseudo; avoid ceftriaxone if prior ESBL

47
New cards

Pip-tazo dose – cUTI

4.5 g q8h

48
New cards

Newer agents (cefiderocol, novel BL/BLIs)

Reserve for resistant pathogens

49
New cards

IV-to-PO switch criteria

Improving, tolerating PO, effective oral option

50
New cards

cUTI duration

FQ: 5–7 days; non-FQ: 7 days

51
New cards

Gram-neg bacteremia from urine – duration

7 days (not 14)

52
New cards

cUTI duration is counted from

First day of effective therapy

53
New cards

Prostatitis duration

2–4 weeks

54
New cards

Prostatitis drugs

FQs (best studied) or Bactrim (penetrate prostate)

55
New cards

Bactrim limitation in prostatitis

Weak vs. Enterococcus; no Pseudomonas

56
New cards

UTI rule in pregnancy

Treat all UTIs + asymptomatic bacteriuria (≥100,000 CFU/mL)

57
New cards

Preferred UTI drug in pregnancy

Cephalexin x 5–7 days

58
New cards

Other pregnancy UTI options

Amox-clav (high resistance), nitrofurantoin, fosfomycin (not for pyelo)